Friday, March 05, 2021 6:26:19 AM
Upcoming milestones:
Expect to begin dosing patients in the first antibiotic cohort of the SYN-004 Phase 1b/2a clinical trial during Q1 2021; A topline data readout of the first antibiotic cohort is expected during Q4 2021
Expect to commence first Phase 1 single-ascending-dose study ("SAD") of SYN-020 during Q2 2021; Topline data anticipated during Q3 2021
Expect to commence second Phase 1 multiple-ascending-dose ("MAD") study of SYN-020 during Q3 2021; Topline data anticipated during Q2 2022
https://finance.yahoo.com/news/synthetic-biologics-reports-2020-end-211000922.html
I started buying again yesterday myself!!
Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?
"We hope not." Richard Dennis
Recent TOVX News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/02/2024 02:53:47 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/30/2024 09:13:32 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 07:20:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2024 08:10:34 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/26/2024 04:15:15 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/23/2024 12:20:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 12:10:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/18/2024 09:06:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 12:10:34 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 12:45:02 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/10/2024 09:03:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:11:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 12:22:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:21:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:20:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 11:30:14 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:10:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:05:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM